Forgot your password?
Meta-analysis of recent drug trials for Galderma’s Nemluvio (nemolizumab) have evaluated its efficacy and safety in the treatment of prurigo nodularis (PN), highlighting strong therapeutic potential.
A new pre-filled syringe version of Shingrix, GSK’s vaccine for shingles, has received a positive opinion from the European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP).
New findings from Johnson & Johnson’s global ENCOMPASS study have revealed significant unmet needs, as well as patient and provider treatment preferences, in psoriasis.
The rare skin conditions affect approximately 500,000 people globally
Around 30% of psoriasis patients are affected by psoriatic arthritis
The drug already holds approvals for indications including atopic dermatitis
More than 26 million people in the US are currently living with the inflammatory skin condition
The candidate has already been granted FDA fast track designation for atopic dermatitis
Around 70% of patients with severe cases report problems performing everyday activities
Approximately 40% of atopic dermatitis patients have moderate or severe symptoms